Letter

Nature 448, 700-703 (9 August 2007) | doi:10.1038/nature06029; Received 4 August 2006; Accepted 18 June 2007; Published online 25 July 2007

A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord

Yan-Gang Sun1 & Zhou-Feng Chen1,2,3

  1. Department of Anesthesiology,
  2. Department of Molecular Biology and Pharmacology,
  3. Department of Psychiatry, Washington University School of Medicine Pain Center, St Louis, Missouri 63110, USA

Correspondence to: Zhou-Feng Chen1,2,3 Correspondence and requests for materials should be addressed to Z.F.C. (Email: chenz@wustl.edu).

Itching, or pruritus, is defined as an unpleasant cutaneous sensation that serves as a physiological self-protective mechanism to prevent the body from being hurt by harmful external agents. Chronic itch represents a significant clinical problem resulting from renal diseases and liver diseases, as well as several serious skin diseases such as atopic dermatitis1, 2, 3. The identity of the itch-specific mediator in the central nervous system, however, remains elusive. Here we describe that the gastrin-releasing peptide receptor (GRPR) plays an important part in mediating itch sensation in the dorsal spinal cord. We found that gastrin-releasing peptide is specifically expressed in a small subset of peptidergic dorsal root ganglion neurons, whereas expression of its receptor GRPR is restricted to lamina I of the dorsal spinal cord. GRPR mutant mice showed comparable thermal, mechanical, inflammatory and neuropathic pain responses relative to wild-type mice. In contrast, induction of scratching behaviour was significantly reduced in GRPR mutant mice in response to pruritogenic stimuli, whereas normal responses were evoked by painful stimuli. Moreover, direct spinal cerebrospinal fluid injection of a GRPR antagonist significantly inhibited scratching behaviour in three independent itch models. These data demonstrate that GRPR is required for mediating the itch sensation rather than pain, at the spinal level. Our results thus indicate that GRPR may represent the first molecule that is dedicated to mediating the itch sensation in the dorsal horn of the spinal cord, and thus may provide a central therapeutic target for antipruritic drug development.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

Extra navigation

.

Open Innovation Challenges

  • Single-cell Analysis Platform

    • Deadline: Dec 02 2009
    • Reward: $5,000 USD

    This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...

  • Optimizing Sub-cellular Localization Tags

    • Deadline: Nov 29 2009
    • Reward: $20,000 USD

    The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....

naturejobs

ADVERTISEMENT